key: cord-0813409-n0lp3bkf
authors: Vanderboom, Patrick M.; Mun, Dong-Gi; Madugundu, Anil K.; Mangalaparthi, Kiran K.; Saraswat, Mayank; Garapati, Kishore; Chakraborty, Rana; Ebihara, Hideki; Sun, Jie; Pandey, Akhilesh
title: Proteomic signature of host response to SARS-CoV-2 infection in the nasopharynx
date: 2021-08-14
journal: Mol Cell Proteomics
DOI: 10.1016/j.mcpro.2021.100134
sha: 4fe49593b9ea05425c994b2b5a366eda6b2d2099
doc_id: 813409
cord_uid: n0lp3bkf

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 infection has become a global health pandemic. COVID-19 severity ranges from asymptomatic infection to severe multi-organ disease. Although the inflammatory response has been implicated in the pathogenesis of COVID-19, the exact nature of dysregulation in signaling pathways has not yet been elucidated underscoring the need for further molecular characterization of SARS-CoV-2 infection in humans. Here, we characterize the host response directly at the point of viral entry through analysis of nasopharyngeal swabs. Multiplexed high resolution mass spectrometry-based proteomic analysis of confirmed COVID-19 cases and negative controls identified 7,582 proteins and revealed significant upregulation of interferon-mediated antiviral signaling in addition to multiple other proteins that are not encoded by interferon-stimulated genes (ISGs) or well-characterized during viral infections. Downregulation of several proteasomal subunits, E3 ubiquitin ligases, and components of protein synthesis machinery was significant upon SARS-CoV-2 infection. Targeted proteomics to measure abundance levels of MX1, ISG15, Stat1, RIG-I and CXCL10, detected proteomic signatures of interferon-mediated anti-viral signaling that differentiated COVID-19 positive from negative cases. Phosphoproteomic analysis revealed increased phosphorylation of several proteins with known antiviral properties as well as several proteins involved in ciliary function (CEP131 and CFAP57) that have not previously been implicated in the context of coronavirus infections. Additionally, decreased phosphorylation levels of AKT and PKC, which have been shown to play varying roles in different viral infections, were observed in infected individuals relative to controls. These data provide novel insights that add depth to our understanding of SARS-CoV-2 infection in the upper airway and establish a proteomic signature for this viral infection.

Host Response to SARS-CoV-2 Infection 

Coronaviruses are enveloped, non-segmented, positive sense RNA viruses of the family Coronaviridae and subfamily Coronavirinae. Human alpha-coronavirus (hCoV) infections have traditionally been associated with mild upper respiratory symptoms and account for a large percentage of "common colds" (1) (2) (3) . Over the past 18 years, however, three separate betacoronaviruses have crossed the species barrier to become lethal zoonotic human pathogens. Severe Acute Respiratory Syndrome Coronavirus (SARS), which emerged in 2002, infected 8,098 individuals resulting in 744 deaths. In 2014, the Middle East Respiratory Syndrome Coronavirus (MERS) infected 2,494 individuals resulting in 898 fatalities (4) . SARS-CoV-2, the virus responsible for COVID-19 has already resulted in a global pandemic with millions of people infected worldwide.

Interferon (IFN)-mediated antiviral response forms the first line of defense against viral pathogens in which the infected host epithelial cells recognize viral pathogen-associated molecular patterns (PAMPs) such as uncapped mRNA or replication intermediates (5) via cytosolic (RIG-I, MDA5) or endosomal (TLR3, TLR4) pathogen recognition receptors (PRRs) ( Figure 1A) . Virus recognition by PRRs triggers a cascade of downstream signaling events leading to activation of transcription factors nuclear factor kB (NF-kB) and IFN regulatory factors 3 and 7 (IRF3 and IRF7) mediating the expression of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α), type I (IFN-α, IFN-β) and type III interferons (IFN-λ) respectively (6) . Infected cells secrete IFNs, which signal in an autocrine and paracrine manor, to establish an antiviral state in the cells through inhibition of viral transcription, translation, and replication, as well as degradation of viral nucleic acids and recruitment of immune cells (7) . Although the transcriptional responses to type I and type III IFNs are similar, cell type-specific expression of receptors and signaling kinetics lead to distinct responses. Type III IFN (IFN-λ) signaling is less potent, slowly induced but more sustained relative to the type I IFN response, which is more potent, rapidly induced and transient (6, 8) . Most nucleated cells express heteromeric cell surface receptors (IFNAR1 and IFNAR2) that mediate responses to type I IFNs. Epithelial cells, however, preferentially express the heteromeric receptors for IFN-λ (IFNLR1 and IL10Rβ). Thus, type III IFN signaling plays an important role in antiviral protection of the upper and lower respiratory, gastrointestinal, and reproductive tracts (8) (9) (10) (11) .

SARS-CoV and MERS-CoV exploit various strategies to mitigate the host immune response. SARS-CoV-encoded nsp1 protein inhibits host gene expression by promoting host mRNA degradation (12) while papain-like protease (PLP) and ORF3b proteins inhibit IRF3 phosphorylation and prevent its translocation to the nucleus. PLP also inhibits NFκB activation by preventing the degradation of IκBα (13, 14) . Further, MERS-CoV ORF 4a, 4b and 5 proteins antagonize IFN production by inhibiting nuclear localization of IRF3 thereby preventing IFN promotor activation (15) . SARS-CoV-2 is genetically more similar to SARS-CoV, sharing 79% of its genomic sequence identity compared to MERS, which shares only 50% genomic sequence identity to SARS-CoV-2 (16) . Despite genomic differences among the three human beta-CoVs, their clinical features are similar. Common symptoms of COVID-19 include fever, dry cough and fatigue, however, severe cases can result in pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, and death (4, 17) . Similar to SARS and MERS, increasing age and underlying health comorbidities including diabetes, obesity and heart failure are associated with increased risk of poor outcomes in patients infected with SARS-CoV-2 (17) (18) (19) (20) (21) (22) (23) (24) (25) .

Previous studies of SARS and MERS indicate that direct cytopathic effects caused by these viruses along with evasion of host immune response are factors affecting disease severity (26, 27) . A number of recent reports have sought to characterize SARS-CoV-2 infection in an effort to understand its pathogenesis, identify prognostic markers and to discover potential therapies. Accurate and specific methods of SARS-CoV-2 detection by mass spectrometry have been developed (28) (29) (30) (31) (32) to complement RT-PCR based testing. Interaction of host proteins with virusencoded proteins have been elucidated using cell culture experiments and potential drugs to target these interactions have been identified (33). Multi-omics analysis of peripheral blood samples from COVID-19 patients utilizing RNA-Seq and high-resolution mass spectrometry identified over 200 molecular features with high correlation to COVID-19 status and severity (34) . Changes in protein phosphorylation upon SARS-CoV-2 infection in an African green monkey kidney cell model (Vero E6 cells) suggested that a major portion of the host response to SARS-CoV-2 infection is driven by phosphorylation signaling (35) . Additionally, peripheral blood mononuclear cells from patients hospitalized for COVID-19 display heterogeneous ISG signatures, downregulation of HLA class II molecules and a neutrophil population that may be characteristic of ARDS (36) .

Both clinical and animal model studies have shown that a dysregulated immune response resulted in hyper-inflammation-induced organ damage, a major contributing factor to disease severity in SARS and MERS (18, 37) . Transcriptional profiling of cell and animal model systems have shown that SARS-CoV-2 pathology is driven by an elevated inflammatory signature characterized by low levels of type I and type III IFNs combined with increased levels of chemokines (38) . Consistent with these results, a transcript level comparison of white blood cells from infected subjects with varying disease severity found that severe and critical cases are associated with impaired type1 IFN signaling and an increased inflammatory response (39) . Quantitative proteomics analysis of urine from SARS-CoV-2 positive individuals also showed dysregulated immune response with decrease abundance of several proteins indicative of renal damage such as NPHS2, SLC36A2, SLC5A10 (32) . Additionally, a single cell RNA sequencing (scRNAseq) study using nasopharyngeal (NP) swabs demonstrated that COVID-19 severity correlates with increased epithelium-immune cell interactions (40) .

Because the exact mechanisms underlying this dysregulated immune response have not yet been determined, we sought to characterize the proteomic and phosphoproteomic response to SARS-CoV-2 infection directly at the point of infection using clinical samples with multiplexed untargeted proteomics. Our data demonstrate a robust IFN-mediated antiviral response in the nasopharynx of SARS-CoV-2 positive individuals and additionally identified several upregulated proteins not previously associated with antiviral responses. Phosphoproteomic analysis revealed regulation of several molecules with known antiviral effects and downregulation of several important signaling molecules including AKT and PKC. These data also implicate opioid growth factor receptor signaling in SARS-CoV-2 infection for the first time. Finally, through targeted mass spectrometric analysis of several key molecules involved in the IFN-mediated response, we demonstrate that levels of these antiviral and pro-inflammatory responses can help monitor the infection and may be of prognostic value.

J o u r n a l P r e -p r o o f

For the global and phosphoprotomics studies protein was extracted from a total of 16 biological replicate NP swabs, 8 of which were from individuals with confirmed SARS-CoV-2 by rtPCR and 8 of which were from negative controls. Subject information for SARS-CoV-2 infected individuals is summarized in (Table S1 ). Samples were labeled with TMT-Pro, analyzed in the MaxQuant software environment and differential analysis was carried out using a generalized linear model as previously described (41) . For the targeted analysis NP swabs from 24 additional biological replicates were analyzed (negative controls, n = 6; low viral load, n = 6, high viral load, n = 6; indeterminate, n = 6). All targeted data was analyzed in Skyline (42) and Student's T-test was used to test for differences between groups using SIL normalized peak areas.

COVID-19 positive and negative NP swabs were selected from samples submitted to the Clinical Microbiology Laboratory at the Mayo Clinic in Rochester, MN, for routine testing. All samples were collected in PBS and obtained with approval from the Mayo Clinic Institutional Review Board. The work described in this study abides by the Declaration of Helsinki principles.

NP swab samples were thawed and immediately treated with HALT phosphatase inhibitor cocktail (Thermo Scientific, Waltham, MA). As the NP swabs used for this experiment were residual clinical samples the volume remaining for each was variable and ranged between 1-2ml of PBS each. Each sample was aliquoted into multiple microcentrifuge tubes (200ul aliquots) and protein was precipitated with the addition of methanol to a final concentration of 90%. Samples were then centrifuged at 15,000 x g for 10min and protein pellets from each sample were re-suspended in a total of 200 µl of 8M urea in 100mM Tris pH 8.0. Samples were then probe sonicated to ensure each pellet was completely dissolved, and protein content was estimated by BCA assay (Pierce, Waltham, MA). Disulfide bonds were reduced and alkylated with 10 mM TCEP and 10 mM IAA at RT for 30 min while protected from light. Trypsin/Lys-C Mix (Promega, Madison, WI) was added at a 1:50 enzyme to protein ratio and samples were digested overnight (16 hr) at 37°C. The enzymatic digest was terminated by adding TFA to a final concentration of 0.2% and peptides were desalted using a 10 mg Strata-x PSVDB cartridge (Phenomenex, Torrance, CA), dried, and reconstituted in 100 µl of 50 mM TEAB. Peptide concentration was determined using a Pierce Colorimetric peptide assay and 95µg from each sample was labeled with TMT-Pro (Thermo Scientific) for 1hr.

TMT labeled peptides were fractionated by high pH reversed phase liquid chromatography on Dionex Ultimate 3000 (Thermo Scientific, Waltham, MA). Peptides (1.6 mg) were separated on a 4.6 mm x 50 cm x 3.5µm Xbridge column (Waters, Milford, MA) with a 2 h gradient from 2 to 40% B mobile phase B (MPB). MPA was composed of 20 mM ammonium formate in water and MPB was composed of 20 mM ammonium formate in 80% ACN. A total of 96 fractions were J o u r n a l P r e -p r o o f collected and concatenated into 24 fractions. A 20µg equivalent of each fraction was set aside for global proteome analysis and the rest of each sample was concentrated into 12 fractions and dried prior to phosphopeptide enrichment.

Each fraction was reconstituted in 100 µl of 80% ACN in 0.1% TFA and transferred to 96 well plate. IMAC-based phosphopeptide enrichment was performed using Fe(III)-NTA resin (G5496-60082) on an AssayMap Bravo (Agilent Technologies, Santa Clara, CA) platform following the manufactur's instructions.

Fractionated, TMT-labeled peptides (5 µg) were loaded onto a 20 mm x 0.075 mm PepMap C18 trap column with loading solvent composed of 0.1% TFA flowing at 20 µl/min using an Ultimate 3000 nano HPLC (Thermo Scientific, Waltham, MA). After 4 minutes, the 10-port valve was switched and peptides were eluted off the trap column onto a 50 cm x 75 µm ID PepMap EASY-Spray analytical column and peptides were separated with a 2 hr gradient from 3 to 40% mobile phase B (MPB). At 2 hr, MPB was increased to 80% over 10 min, held for 15 min, and then returned to 3% for 5 minutes to re-equilibrate the column. The flowrate was set to 300 nl/min. Eluting peptides were analyzed on an Orbitrap Fusion Lumos (Thermo Scientific, Waltham, MA) mass spectrometer operated in data dependent mode. MS1 scans were acquired from 370-1700 m/z with an orbitrap resolution of 60,000 (at 200 m/z) at least every three seconds or when no more peptides were scheduled for fragmentation. The automatic gain control (AGC) was set at 1e6 and maximum ion fill time was set to 50 ms. The most abundant peptides with a charge state between 2 and 7 were selected for fragmentation with high-energy collision induced dissociation (HCD) using a normalized collision energy of 35% and a quadrupole isolation width of 0.7 m/z. The orbitrap resolution was set to 30,000, the maximum injection time was set to 54 ms, and the AGC target was set to 2e5 whereas the dynamic exclusion was set to 30 sec using a 10 ppm mass window. For phosphopeptide analysis, the resolution for MS/MS was set to 50,000 and the maximum injection time was set to 86ms.

MS raw files were processed in MaxQuant software version 1.6.7.0 (43). Peptides were searched using the Andromeda search engine against the human Uniprot FASTA database downloaded July 24, 2019 concatenated with SARS-CoV-2, SARS-CoV, and MERS proteins for a total of 20,499 protein sequences. Enzyme specificity was set to Trypsin/P, and maximum missed cleavages was set to 2 or less. Mass tolerance for the first search was set to 20ppm and 4.5ppm for the main search. Cysteine carbamidomethylation was set as a fixed modification and N-terminal acetylation, methionine oxidation and phosphorylated serine, threonine and tyrosine were set as variable modifications. Searches were performed with a false discovery rate of 1% for both peptides and proteins using a target-decoy approach. Peptide length was to at least 7 amino acids long and MS2

J o u r n a l P r e -p r o o f match tolerance was set to 0.02 Da. Enzyme specificity was set to trypsin and a maximum of 2 missed cleavages were allowed. Protein data was extracted from the "proteinGroups.txt" file and differential quantitation was carried using a generalized linear model as previously described (41) .

For targeted PRM analysis, samples were prepared as stated above for global and phosphoproteomic analysis except phosphatase inhibitors were not used. Stable isotope labeled internal standards with isotopically labeled C-terminal arginine or lysine were synthesized by the Mayo Clinic Proteomics Core and spiked into each sample. Peptides were separated using a nano-HPLC set up identical to the configuration described above. For all samples, 250ng of protein was loaded on to the trap column with loading solvent flowing at 20µl/min and washed for 4 minutes.

The valve was then switched and the peptides were eluted onto the analytical column and separated with a 20 minute gradient from 2 to 40% mobile phase B (MPB). Target peptides were monitored using an Orbitrap Eclipse (Thermo Scientific, Bremen, Germany) mass spectrometer using and inclusion list with scheduled retention times. The parameters for the PRM scan were set as follows: AGC target was set to 5e4, maximum injection time was set to 54ms, orbitrap resolution was set to 30,000, HCD normalized collision energy was set to 28%, and the quadrupole isolation was set to 1.6 m/z. The chromatographic peaks were manually integrated using the Skyline-daily software package. Peak areas for the top 3 to 5 most intense fragment ions from each target peptide ( Table  2 ) were exported and summed for relative quantitation between groups using a student's t-test in R version 3.6.3.

Gene set enrichment analysis was performed using Broad Institute's GSEA software. All gene sets that were negatively enriched in the COVID-19 positive subjects with an FDR corrected p-value (using the Benjamini-Hochberg procedure) < 0.05 were reported.

The peptide sequences surrounding the phosphorylation site of significantly downregulated entities (7 amino acids on each side of the phosphorylation site) were extracted from the 'Phospho (STY)Sites.txt' MaxQuant output file. Enriched motifs were identified using the Meme Suite online resource (http://meme-suite.org/) with the motif-x algorithm. The significance threshold was set to p < 1e-4 and the minimum occurrence of each motif was set to 20. The high throughput NetworKIN (https://networkin.info/index_ht.shtml) tool was used to identify predicted protein kinases for all phosphosites with a fold change > ±1 and an adjusted p-value of < 0.05. Kinases predicted to phosphorylate the enriched motifs identified using the motif-x algorithm were extracted from the NetworKIN output.

Upon viral infection, interactions between immune and epithelial cells result in transcriptional activity that is cell type-specific and integral to host-pathogen defense (44, 45) . Dysregulation of these interactions can be deleterious resulting in severe cases of COVID-19 (40) . Nasopharyngeal swabs are comprised of a heterogeneous mixture of cells of both epithelial and immune origins (40, 46) . The nasopharynx is also the point of infection for SARS-CoV-2 and in close proximity to the lungs, where the majority of tissue damage occurs in severe cases of COVID-19. Therefore, NP swabs are an excellent and also accessible sample to study SARS-CoV-2 infection. We hypothesized that a comparative analysis between SARS-CoV-2 positive samples and negative controls should shed light on unique molecular features involved in the host response to SARS-CoV-2 infection. To this end, NP swab samples from patients who underwent PCR-based molecular testing were chosen for analyzing host responses to SARS-CoV-2. This included eight individuals who tested positive and eight individuals who tested negative.

To perform a multiplexed quantitative proteomic analysis, protein was extracted from NP swabs with methanol precipitation, digested with trypsin and labeled using tandem mass tags (TMT) ( Figure 1B) . The labeled peptides were mixed and fractionated into 24 fractions using basic reversed phase fractionation and subjected to LC-MS/MS analysis on an Orbitrap Fusion Lumos mass spectrometer (Thermo, San Jose, CA). After removing common contaminants and decoy sequences, we identified 7,582 proteins of which 143 were upregulated and 80 were downregulated in SARS-CoV-2-infected patients (adjusted p-value <0.05 and a fold-change >±2) (Figure 2 A, B, Table S2 ).

To investigate IFN signaling in the nasopharynx of SARS-CoV-2-infected individuals, upregulated proteins were compared to a publicly available database of genes known to be increased by different types of IFNs using the web-based tool, Interferome (47) . The majority of proteins that were significantly upregulated in infected subjects (70.4%) were annotated in the Interferome database as proteins upregulated upon IFN treatment in at least one dataset, confirming that these proteins are IFN responsive. These proteins include most of the classical ISGs -IFIT1/2/3, MX1/2, ISG15/20, OAS1/2 and HERC5/6 ( Table 1) . Additionally, several molecules with different roles in IFN signaling were upregulated in infected subjects. Pathogen recognition receptors, IFIH1 (MDA5) and DDX58 (RIG-I), which are activated by intracellular viral RNA and lead to downstream type 1 IFN signaling through mitochondrial antiviral signaling protein (MAVS), were upregulated in infected individuals. Additionally, transcription factors STAT1, STAT2, and IFR9 as well as pro-inflammatory cytokines CXCL10 and CXCL11 were upregulated in infected individuals. Targets of type I (IFN-α/β), type II (IFN-γ) and type III (IFNλ) IFN signaling were all upregulated in infected subjects when referenced against the Interferome J o u r n a l P r e -p r o o f database ( Figure 2C , Table 1 ). Twelve proteins were specific to type I IFN signaling and an equal number were specific to type II IFN signaling. (Figure2C, Table 1 ). Most upregulated proteins; however, were known to be common mediators of multiple types of IFNs. This overlap of IFN signaling types is expected. Epithelial cells of the upper airway express type I (IFNAR) and type III (IFNLR) IFN receptors (6, 8) , the latter of which are selectively expressed in epithelial tissue and play an important role in innate viral defense at barrier surfaces (8, 48) . Additionally, secretory and ciliated cells in airway epithelium express IFN-γ receptors (IFNGR1 and IFNGR2), and thus respond to type II IFN (IFN-γ) secreted from natural killer (NK), CD4 + T helper cells and CD8 + cytotoxic T lymphocytes (CTLs) (40) . It is known that the induction of target ISGs resulting from all three types of IFN signaling overlap to a great degree, but differ primarily by magnitude and duration (8, 48) . Therefore, IFN-mediated antiviral signaling in epithelial cells of the upper airway can result from complex interactions between all three types of IFN signaling. These signatures were detected by deep proteomic analysis of NP swabs.

Although some heterogeneity among subjects is noted, our findings suggest that there is a distinct IFN-mediated antiviral response in the nasopharynx of SARS-CoV-2-infected individuals and contrasts with several recent reports utilizing cell line models to study the host response to SARS-CoV-2 (38, 39, 49, 50) . These studies reported that SARS-CoV-2 infection did not induce major IFN signaling, but rather increased the expression of pro-inflammatory cytokines and chemokines. The diminished ISG expression observed upon SARS-CoV-2 infection in cell culture may indicate an impaired type I or type III IFN response. This is supported by a recent study of infected humans with varying disease severity which found a downregulation of ISG transcripts in peripheral white blood cells of critically ill patients relative to moderately ill patients (39) . The apparent discrepancy between our study and these reports may reflect the sample type used. As mentioned above, NP swabs contain a heterogeneous mixture of epithelial and immune cell subtypes as confirmed by identification of immune cell-specific (CD2, CD5, CD8, CD14, CD20 and granzyme B) and epithelial cell-specific (CDH1, ACE, CLDN3) markers in the proteomic data. The release of type I or type III IFNs from myeloid cells or IFN-γ from lymphocytes recruited to the site of infection could activate IFN receptors on epithelial cells and stimulate the expression of ISGs -this would not be observed in cell culture-based studies. These results are in agreement with a recent study that utilized single cell RNA sequencing to analyze NP and bronchial samples to demonstrate increases in immune and epithelial cell interactions during severe SARS-CoV-2 infection (40) (Figure 3A) . In order to assess the differences of SARS-CoV-2 infection in cell culture and in humans, we compared proteins which have recently been reported to be differentially regulated upon SARS-CoV-2 infection of normal human bronchial epithelial cells (NHBE) (49) with those identified in our study. Surprisingly, only four proteins were found to be differentially regulated in both NHBE cells and NP swabs from infected humans (Figure S1 ), highlighting the differences between these sample types including the role of the microenvironment. We also compared the results of our study to a recent plasma proteomics investigation of SARS-CoV-2 infected individuals (34) . This comparison found only one upregulated protein that was in common between NP swabs and plasma ( Figure S2 ). Our results underscore the importance of studying intact systems using infected cells harvested from the viral route of entry. These data also indicate that IFN signaling is engaged in SARS-CoV-2 subjects; however, a deficiency in type I IFN signaling could be masked by type II IFN signaling mediated by immune and epithelial cell interactions. Although IFN signaling appears to be engaged, the present study was not designed to investigate differences between various clinical outcomes. Additionally, global proteomic differences in NP swabs between severe and moderate cases of COVID-19 remains to be determined.

The expression of specific ISGs has been utilized as biomarkers of disease progression, treatment response, and prognostic outcome in preclinical studies (51) (52) (53) (54) (55) . Considering the wide variation in disease severity among patients infected with SARS-CoV-2, we chose to monitor two molecules involved in type I IFN signaling (RIG-I and STAT1) and three other key ISGs (MX1, ISG15 and CXCL10) using a tier 2 targeted proteomics analysis to study the biological variability of these molecules in NP swabs ( Table 2) . For this study, 24 independent samples with different viral loads (based on quantitative RT-PCR results) were analyzed (high viral load: n=6, low viral load: n=6, negative: n=6, indeterminate: n = 6). Proteotypic target peptides were selected based on uniqueness to each protein in the human and viral (SARS-CoV-2, SARS, and MERS) proteome background. Amino acids subject to common modifications were avoided, when possible ( Table 2) . Stable isotope-labeled standard peptides were synthesized for all targets and spiked into samples for accurate relative comparison across groups. There was a clear increase in the monitored proteins between uninfected individuals and those who tested positive for SARS-CoV-2 ( Figure 3B , Figure S3 ). Although a trend of increased levels in those with higher viral loads was seen, it was not statistically significant for all proteins. Interestingly, the abundance of ISGs in some of the samples which were indeterminate by RT-PCR was higher than the negative controls. Although there is no other clinical data available on the patients with indeterminate results, our findings raise the possibility that ISG abundance can detect signs of viral infection even when RT-PCR results are indeterminate. The abundance of ISGs, MX1and ISG15, correlate well with each other and with IFN signaling molecules STAT1 and RIG-I, displaying an average pearson correlation coefficient of 0.67 (s = 0.096) ( Figure 3C ). In contrast, the abundance of CXCL10 did not correlate well with other ISGs, STAT1 or RIG-I (average r = 0.39, s = 0.178). To test for differences in correlation between CXCL10 and the other IFN signaling proteins, we used the R package cocor (56) . This analysis found that CXCL10 abundance had a significantly lower correlation to ISG15, MX1 and RIG-I relative to correlations within each of these respective proteins (CXCL10/MX1 vs ISG15/MX1: p = 0.049, CXCL10/ISG15 vs ISG15/MX1: p = 0.016, CXCL10/RIG-I vs RIG-I/ISG15: p = 0.023, CXCL10/RIG-I vs RIG-I/MX1: p = 0.028). The CXCL10 promoter includes response elements for several transcription factors including IRF1, STAT-1, AP1, FoxA2a NF-κB and several others (57, 58) . These results may indicate that the pro-inflammatory cytokine CXCL10 is regulated separately from other ISGs and could potentially serve as a prognostic indicator to predict the magnitude of inflammatory response in individuals infected with SARS-CoV-2.

Previous reports have shown that treatment with DS RNA and IFN-γ results in synergistic upregulation of CXCL10 in an NFκBdependent and STAT1-independent manner (59). These results indicate that targeted analysis of interferon signaling proteins could be a valuable research tool to help elucidate mechanisms of dysregulated inflammatory response to SARS-CoV-2.

We next sought to catalog proteins that are independent of the IFN signaling pathways. To accomplish this, IFN-responsive proteins in the Interferome database were filtered from the list of upregulated proteins in SARS-CoV-2 infected individuals. After filtering, a total of 6 proteins including WWTR1, PPIAL4F, OPRPN, LSG1, TCF25 and EPN2 were left in the list of upregulated proteins. Most of these proteins have not been extensively characterized in viral infection. WWTR1, a Hippo signaling effector protein, that acts as a transcriptional co-activator and is involved in organ size control and tumor suppression by inhibiting proliferation and promoting apoptosis. Protein levels and methylation status of WWTR1 have been shown to be regulated during Zika virus infection, negatively regulating the Hippo signaling pathway (60, 61) . The most highly upregulated protein in infected individuals was PPIAL4F, a peptidyl-prolyl cis/trans isomerase (PPIase), which functions to accelerate protein folding. Host PPIases have been shown to be important for efficient infection in several different viral infections, including SARS-CoV (62) . Additionally, the PPIases, cyclophilin A and B, have been shown to bind the capsid protein of HIV-1 (63) . Opiorphin prepropeptide (OPRPN) was also upregulated in an IFNindependent manner. Opiorphin, a 5 amino acid peptide derived from the N-terminus of OPRPN, has many proposed functions including inhibition of aminopeptidase N and MME (neprilysin); however, its role in viral infection is currently uncharacterized. LSG1, a GTPase involved in the biogenesis of the 60S ribosome (64) has not been studied in the context of viral infections. TCF25, a transcription factor, is also a poorly characterized component of the ribosome-associated quality control pathway that mediates K-48 linkage of ubiquitin to the nascent chain of stalled ribosomal complexes (65) . Finally, EPN2 plays a role in mediating recruitment of clathrin to the cell membrane and promotes its polymerization to mediate endocytosis (66) . Knockdown of EPN2 using siRNA was shown to inhibit infection of Huh7 cells by Dengue virus indicating that it may be important in viral entry (67) . The IFN-independent upregulation of these proteins makes them attractive candidates for future studies characterizing the pathogenesis of SARS-CoV-2 infection at a cellular level.

Although viruses have evolved sophisticated mechanisms to promote their proliferation, they remain completely dependent upon the host translational machinery for protein synthesis. Thus, it is not surprising that host cells respond to viral infection by inhibiting protein synthesis and disrupting mRNA transport (68) (69) (70) . Consistent with these events, many proteins in SARS-CoV-2-infected individuals decreased in abundance relative to uninfected controls in our dataset. EIF2AK2, which was upregulated, is a well-known antiviral protein induced by IFNs. EIF2AK2 mediates translation inhibition of host and viral mRNAs through phosphorylation of eIF2α (69) (Figure 1A) . In agreement with this, we observed downregulation of several ribosomal subunits including RPLP2, MRPL12, and MRPL41. Further, downregulation of host proteins has also been linked to SARS-CoV-2 nsp1, which has been shown to bind and to obstruct the ribosomal mRNA entry tunnel (71), potentially exacerbating the reduction in protein synthesis.

The ubiquitin-proteasome system is a major intracellular protein degradation pathway present in all eukaryotes which is primarily responsible for the removal of damaged, misfolded or unfolded proteins in the cell. The ubiquitin-proteasome system is a critical regulator of many basic cellular processes including, protein homeostasis, signaling, chromatin structure, endocytosis, development and immunity (72) . It is now well understood that certain viruses have evolved complex mechanisms to manipulate the host UPS for their own benefit (73, 74) . Additionally, the ubiquitin-proteasome system is required for host immune surveillance and several processes involved in viral propagation including viral genome uncoating, viral replication and immune evasion (75) (76) (77) . Interactions between the ubiquitin-proteasome system and viral proteins are typically studied by overexpressing individual viral proteins or infecting cells in culture.

Gene set enrichment analysis revealed a negative regulation of proteosomal proteins in COVID-19 positive subjects (Table S3 ). Further analysis revealed the downregulation of several proteasomal subunits including PSMC1, PSMD2, PSMD7 and the proteasomal ubiquitin receptor ADRM1 upon SARS-CoV2 infection. Previous studies have implicated proteasomal proteins in viral infection. For instance, inhibition of PSMB1 was shown to positively regulate the innate immune response by increasing the production of IFN-β and proinflammatory cytokine TNF-α (78) . Wholesale downregulation of proteasomal degradation; however, is a less commonly observed host response to viral infection. Some studies have investigated the use of proteasome inhibitors as antiviral agents with promising results (79) (80) (81) (82) , suggesting that proteasomal downregulation may be a host viral defense measure. The effect of proteasomal downregulation with SARS-CoV-2 infection remains to be determined and further studies are required to determine if this is a host-or viral-mediated adaptation.

Over the course of evolution, viruses have adapted to use the ubiquitylation process to favor conditions that promote their survival and replication. In fact, several viruses encode E3 ligases to target specific host proteins for degradation affecting processes including antigen presentation IFN-mediated antiviral defense (83) (84) (85) (86) . We identified a number of differentially regulated E3 ubiquitin-protein ligases in our data. ISG15, a ubiquitin-like protein that mediates antiviral activity via ISGylation of target proteins during viral infection and its E3 ligases, HERC5, and UBE2L6, are upregulated by SARS-CoV-2 infection (87) . We also observed the regulation of several RING domain E3 ligases (RING E3s). RING E3s are involved in several aspects of immune function including regulation of RIG-I signaling and cell surface expression of MHC molecules. RNF213 was upregulated two-fold and RNF181 and RNF126 were downregulated two-fold in this data. RNF213, is involved in angiogenesis (88) (89) (90) (91) and could be related to the observed vascular abnormalities in COVID-19 patients (92, 93) . The role of RNF181 and RNF126, which are downregulated, is not understood although our data suggest that they may mediate SARS-CoV-2induced signaling.

To study the impact of SARS-CoV-2 infection on host signaling, we also undertook a phosphoproteomics analysis of NP swab samples. TMT-labeled tryptic peptides were enriched with immobilized metal affinity chromatography (IMAC) and analyzed by LC-MS/MS. This analysis identified > 8,500 phosphorylation sites, of which 194 were upregulated and 213 were downregulated (>2-fold) (Figure 4 A,B, Table S4 ). These changes were mainly regulated at the phosphorylation level (i.e. the protein level was unchanged) ( Table S5) . Regulated phosphorylation sites were identified in twenty different kinases with an FDR <0.1% ( Table 3) , five of which were upregulated and fifteen downregulated in infected subjects relative to uninfected controls. Similar to the global proteomics data, a comparison of regulated phosphosites between NHBE cells infected with SARS-CoV-2 (49) and the data from our study illustrates markedly different sets of regulated molecules between the two samples types (Figure S1) highlighting the importance of studying host response using both cell line models and cells harvested from infected subjects..

Phosphosites on several proteins involved IFN signaling, RNA processing, and protein synthesis were regulated in infected individuals. Increased phosphorylation of Serine 478 on IFIT3, a well characterized ISG with antiviral effects, was observed in infected subjects. Additionally, increased phosphorylation sites on two RNA binding proteins, RBM12B and RBM10, were also observed in infected individuals. Furthermore, phosphosites on several proteins involved in protein translation including EIF6, EIF4EBP1 and EIF4G3 were downregulated in infected subjects. The observed increase in RNA binding and decrease in protein synthesis likely reflects an IFNmediated antiviral cellular state that is meant to decrease the translation of host and viral proteins. Currently, there are no comprehensive resources to evaluate phosphorylation events in the context of viral pathogenesis. To investigate role of some interesting molecules which displayed regulated phosphorylation sites, we performed a manual literature search. CEP131, a component of pericentriolar satellites that regulates cilia and flagellum formation, displayed increased levels of phosphorylation on S78 in infected subjects. CEP131 is phosphorylated on Ser 78 by PLK4 to maintain centriolar satellite integrity (94) ; however, its role in viral infection is unknown. Additionally, phosphorylation of Ser 1237 in CFAP57 was decreased in COVID-19 positive subjects relative to negative controls. CFAP57 is a conserved component of motile cilia and flagella (95, 96) that has been shown to form a complex connecting components critical for motility (97) . Cilia and flagella are essential structures for the sense of smell and the regulated phosphorylation of CEP131 and CFAP57 could perhaps be related to the loss of smell (anosmia) associated with SARS-CoV-2 infection.

AKT signaling regulates many critical cellular processes and has been targeted by many viruses for their benefit with widely varying mechanisms (98) . For instance, influenza A has been shown to activate AKT signaling to inhibit apoptosis (99) (100) (101) (102) . In contrast, measles virus can downregulate AKT signaling (103) highlighting the diverse mechanisms that viruses use to interact with the host system for their benefit. In this dataset, infected subjects displayed decreased levels of Ser 126 phosphorylation in AKT1 and Thr 451 phosphorylation in AKT2. Isoform specific phosphorylation of AKT1 and AKT2 has been previously described (104) and phosphorylation of Ser 451 on AKT2 is known to positively regulate AKT signaling (104, 105) . The observed downregulation of AKT signaling in infected subjects is also in agreement with a previous report utilizing SARS-CoV-2-infected Vero E6 cells (35) . The precise mechanism of AKT downregulation during SARS-CoV-2 infection remains to be determined, although the importance of this signaling pathway in regulating critical cellular processes suggests that AKT signaling downregulation by SARS-CoV-2 may play an important role in the course of infection.

PKC signaling has a wide range of effects on cellular signaling and has been shown to be involved in viral entry (106) . PKC-δ Serine 664 phosphorylation was downregulated in infected subjects. The role that PKCs play in viral replication has been controversial although some reports have shown that pharmacological inhibition of PKC signaling reduces replication of West Nile virus (107) . Downregulation of PKC-δ signaling in infected subjects could potentially be a host adaptation to limit viral entry; however, further experiments will be required to elucidate the biological relevance of this phosphorylation event in the context of SARS-COV-2 infection.

Phosphorylation of S55 on opioid growth factor receptor (OGFR) was upregulated 2.2-fold in infected subjects. Phosphorylation of this serine residue has been previously observed although its regulatory role remains unclear (108) (109) (110) . When OGFR binds to its ligand, it negatively regulates cell growth by inhibiting G1-S transition. This action is mediated through OGFR-dependent upregulation of CDK inhibitors p12 and p16, which inhibits CDK4-mediated phosphorylation of retinoblastoma protein (111, 112) . Although neither p12 nor p16 were significantly upregulated in infected subjects, we observed that one of three enriched phosphorylation motifs in the downregulated phosphosites was predicted to be phosphorylated by CDKs 1-4 ( Figure 4C ) thereby providing a possible link between OGFR signaling and cell growth arrest upon SARS-CoV-2 infection.

Opiorphin (OPRPN), whose protein level was increased, has been shown to have many effects although it is most known for its inhibitory effects on the endopeptidases neprilysin and aminopeptidase-N. Neprilysin,a type II transmembrane glycoprotein that inactivates several peptide hormones including glucagon, met-enkephalin, bradykinin, substance P, angiotensin 1 and angiotensin 2, was downregulated in SARS-CoV-2 positive subjects. Opiates and endogenous opioid peptides are known to have immunomodulatory effects and previous reports have linked opioid growth factor receptor signaling to immunosuppression of T-lymphocytes (113) . The observed upregulation of OPRN together with the increased phosphorylation of OGFR on S55 and decreased levels of neprilysin may indicate that the OGFR signaling axis plays a role in response to SARS-CoV-2 infection and warrants further investigation.

In the present study, we employed global proteomics and phosphoproteomics to characterize the host response to SARS-CoV-2 directly at the point of infection using NP swabs. Infected subjects displayed upregulation of 98 proteins known to be stimulated by IFNs, which included classical ISGs (MX1, MX2, ISG15, IFIT1, OAS1 and IDO), PRRs (MDA5, DDX58), transcription factors (IRF9, STAT1, STAT2) and pro-inflammatory cytokines (CXCL10 and CXCL11). In contrast to previously published studies that mimicked SARS-CoV-2 infection using cultured cell lines, IFNmediated antiviral responses appear to be robust in the nasopharynx of infected subjects. The discrepancy between previous cell line studies and the clear evidence of type I and type II IFNmediated effects presented here indicate that epithelial and immune cell interactions in the microenvironment is required to mediate the entire spectrum of host responses to SARS-CoV-2 infection. Targeted analysis of IFN signaling molecules STAT1 and RIG-I along with the key ISGs, MX1, ISG15, and the pro-inflammatory cytokine CXCL10 demonstrate that levels of these antiviral proteins generally correlate with the viral loads. Although CXCL10, also known as interferon γ-induced protein 10 kDa (IP-10), was upregulated, its correlation with the levels of other ISGs was not high and needs to be investigated further. Other features of SARS-CoV-2 infection apparent from this study include the upregulation of multiple proteins that are not IFNresponsive and have not been well-characterized during viral infection. Additionally, downregulation of several proteasomal proteins and the regulation of several E3 ubiquitin ligases was observed in infected subjects. Phosphoproteomic profiling indicates that several signaling pathways including AKT, PKC and OGFR are affected and may play a role in SARS-CoV-2 pathology. The current study was not designed to detect differences between patients with clinical outcomes and further studies focusing on these features in individuals with varying outcomes or infection from different viruses may shed additional light on the pathogenesis of COVID-19.

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (114) like plasmacytoid dendritic cells (pDCs) process infected cell debris and produce IFNα. By autocrine and paracrine action, these type I IFNs lead to the expression of interferon-stimulated genes (ISGs) which lead to an intracellular antiviral response. They also lead to increased capillary permeability, leukocyte recruitment, Th0 cell differentiation, and NK-cell mediated killing of infected cells. TCR mediated antigen detection by CD4+ T cells leads to the release of proinflammatory cytokines including Type II IFN (IFN-γ) and effector T cell recruitment. B) Schematic of experimental workflow. For the discovery workflow, protein was extracted from nasopharyngeal swabs (RT-PCR positive: n=8, RT-PCR negative: n=8) digested with trypsin and fractionated using high-pH reversed phase fractionation. Peptides without any enrichment were subjected to global proteome analysis and peptides subjected to phosphopeptide enrichment using immobilized metal affinity chromatography (IMAC) were analyzed separately as shown. Targeted PRM analysis of separate NP swabs samples (high viral load: n=6, low viral load: n=6, negative: n=6, indeterminate: n = 6) was carried out to monitor levels of several key interferon stimulated genes (ISGs).

A) Volcano plot displaying protein expression changes between SARS-CoV-2 infected patients (n=8) and negative controls (n=8). Significantly regulated proteins are colored in red, rows are labeled with gene names. B) Heatmap displaying the Z-score of select proteins with statistically significant changes in abundance between SARS-CoV-2 positive and negative subjects. Rows are subjected to hierarchical clustering and labeled with gene names. C) Venn diagram indicating the number of proteins involved in type I, type II, and type III interferon (IFN) signaling. IFN signaling type was determined using the Interferome database (47) . Supplemental Tables   Table S1 . Summary of subject characteristics. Cycle threshold (CT Value), age and gender of the COVID-19 positive subjects. Table S2 . List of identified proteins. All identified proteins are listed with their corresponding quantitation results and identification information. J o u r n a l P r e -p r o o f INO80  LILRA5  ACCS  SP110  IL4I1  ZBP1  CXCL10  EPSTI1  GCH1  GZMB  GBP1  TCF25  EIF2AK2  RRP1B  IGHG1  MANEA  PPIAL4F  WWTR1  OPRPN  OAS1  UBE2L6  STAT1  IFIT2  OAS3  ISG20  IFIH1  DDX58  ISG15  MX1  CNTRL  IFIT3  IFIT1  APOBEC3G  STAT2  HERC6  HELZ2  OAS2  SAMD9L  MX2  SMN1  TMEM87A  MUC5AC  S100A14  ABCA13  TXN2  PFDN5  GON7  PKIG  SKP1  PEA15  PGRMC1  PEX19  CCDC32  MYCBP  PFDN1  COA4  MIEN1  DNAJC5  CYSTM1  CYB5R1  SLC15A2  LYPD2  SPATA5L1  SLC44A4  CIB1  GSKIP  ARMC6  VTI1B  C9orf40  RNF181  LAMTOR5  COX5A  ADIRF  UMAD1  DDX19B COVID-19  Positive  Z-Score  7  6  5  1 2 3 4  8  7  6  5  1 2 3 4  8   TBC1D9B  ARHGEF16  STRIP1  ASAP2  DCAF15  CCDC40  SPTBN1  OSBP  ARHGEF11  RALGAPA2  PGRMC2  OSBPL3  WRAP53  CLIC6  LYST  AKT2  ASPSCR1  SKP1  SEC31A  FBXW9  PRKCD  CCDC149  COPB2  ADH5  BOLA1  ANAPC4  NAP1L1  SCFD1  AKT1  HUWE1  PAK4  PGRMC1  BDKRB2  TMC4  CFAP57  ARHGAP12  ITGB7  TUSC2  FAM129B  SH2D3A  RANBP2  AKAP17A  SRRM2  SRSF3  RBM10  SRSF4  CCDC137  ZC3H13  ACIN1  NOL8  PPP2R5A  ZYX  ZNF318  CWC22  RLIM  IFIT3  STAT1  THEMIS2  FYTTD1  CBY1  PPIG  SRSF10  SCAF11  PRPF4B  ZC3H3  ERICH3  SP100  SP110  LARP4B  OGFR  CCNL1  SRRM1  TCOF1  CLASP2  TJP1  N4BP1   ISG15 

Detection of coronavirus 229E antibody by indirect hemagglutination

A new virus isolated from the human respiratory tract

Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions

Interferon-stimulated genes and their antiviral effector functions

2020) Type I and Type III Interferons -Induction, Signaling, Evasion, and Application to Combat COVID-19

Regulation of type I interferon responses

Shared and Distinct Functions of Type I and Type III Interferons

Type III interferon signaling restricts enterovirus 71 infection of goblet cells

Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier

IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Comorbidity and its Impact on Patients with COVID-19

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Middle East respiratory syndrome

Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

Coronavirus as a possible cause of severe acute respiratory syndrome

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain

Proliferative growth of SARS coronavirus in Vero E6 cells

A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens

Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts

A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry

Mass-Spectrometric Detection of SARS-CoV-2 Virus in Scrapings of the Epithelium of the Nasopharynx of Infected Patients via

Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response

SARS-CoV-2 protein interaction map reveals targets for drug repurposing

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

SARS and MERS: recent insights into emerging coronaviruses

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Enhanced Protein Translation Underlies Improved Metabolic and Physical Adaptations to Different Exercise Training Modes in Young and Old Humans

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Structural cells are key regulators of organ-specific immune responses

Innate immune cell-epithelial crosstalk during wound repair

Upper Airway Cell Transcriptomics Identify a Major New Immunological Phenotype with Strong Clinical Correlates in Young Children with Acute Wheezing

Interferome v2.0: an updated database of annotated interferon-regulated genes

Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19

Aicardi-Goutières syndrome and the type I interferonopathies

Interferon-&#x3b3;&#x2013;Stimulated Genes, but Not USP18, Are Expressed in Livers of Patients With Acute Hepatitis C

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

Detection of interferon alpha protein reveals differential levels and cellular sources in disease

cocor: A Comprehensive Solution for the Statistical Comparison of Correlations

TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein

Regulation of influenza A virus induced CXCL-10 gene expression requires PI3K/Akt pathway and IRF3 transcription factor

Synergistic Up-Regulation of CXCL10 by Virus and IFN γ in Human Airway Epithelial Cells

Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation

The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma

Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes endoplasmic reticular disruption and cellular senescence

Release of Ubiquitinated and Non-ubiquitinated Nascent Chains from Stalled Mammalian Ribosomal Complexes by ANKZF1 and Ptrh1

Epidermal growth factor pathway substrate 15, Eps15

Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus

PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control

Viral subversion of the host protein synthesis machinery

Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export

Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs

The ubiquitin-proteasome pathway in viral infectionsThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigator's Forum

Pleiotropic roles of the ubiquitin-proteasome system during viral propagation

The Ubiquitin-Proteasome System Is Necessary for Efficient Replication of Human Astrovirus

The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle

Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors

PSMB1 Negatively Regulates the Innate Antiviral Immunity by Facilitating Degradation of IKK-ε

The Clinically Approved Proteasome Inhibitor PS-341 Efficiently Blocks Influenza A Virus and Vesicular Stomatitis Virus Propagation by Establishing an Antiviral State

Repurposing host-based therapeutics to control coronavirus and influenza virus

Early steps in herpes simplex virus infection blocked by a proteasome inhibitor

The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection

RING-Domain E3 Ligase-Mediated Host-Virus Interactions: Orchestrating Immune Responses by the Host and Antagonizing Immune Defense by Viruses

A Novel Family of Membrane-Bound E3 Ubiquitin Ligases

HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity

Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7

ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease

Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling

Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells

Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Pulmonary Vascular Manifestations of COVID-19 Pneumonia

Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131)

Gene expression in a paleopolyploid: a transcriptome resource for the ciliate Paramecium tetraurelia

Tissue expression patterns identify mouse cilia genes

FAP57/WDR65 targets assembly of a subset of inner arm dyneins and connects to regulatory hubs in cilia

Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway

Control of apoptosis in influenza virus-infected cells by upregulation of Akt and p53 signaling

Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K

Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling

Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses

Measles virus induces expression of SIP110, a constitutively membrane clustered lipid phosphatase, which inhibits T cell proliferation

Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules

Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions

Protein Kinase C Signaling in Adenoviral Infection

Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication

Toward a comprehensive characterization of a human cancer cell phosphoproteome

Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project

Integrated proteomic analysis of post-translational modifications by serial enrichment

Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers

The Opioid Growth Factor (OGF)-OGF Receptor Axis Uses the p16 Pathway to Inhibit Head and Neck Cancer

enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases

The PRIDE database and related tools and resources in 2019: improving support for quantification data

Author Contributions Conceptualization: AP, PMV; Methodology: DM, PMV; Formal Analysis: PMV, AKM; Investigation: PMV, KKM

Supervision: AP; Project Administration: AP; Funding Acquisition: AP to SARS-CoV-2 infection underlies severe disease, however, the precise underlying mechanisms have not yet been elucidated. To establish a proteomic signature of SARS-CoV-2 infection in the upper airway the authors of this study performed a deep proteomic and phosphoproteomic analysis of nasopharyngeal swabs. This study is a valuable resource for investigators

This study was supported by DBT/Wellcome Trust India Alliance Margdarshi Fellowship grant IA/M/15/1/502023 awarded to AP and the generosity of Eric and Wendy Schmidt.

The authors declare no competing interests.

The authors declare no competing interests.